Mustang Bio (MBIO) analyst forecast and price target
Analyst forecast
Consensus of 1 analyst rating
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $2.00 | May 16, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $2.00 from $25.00 | May 13, 2024 |
| Cantor Fitzgerald | Maintained | Overweight | $18.00 | Aug 24, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $25.00 | Aug 16, 2023 |
| BTIG | Maintained | Buy | $16.00 from $20.00 | Aug 15, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $25.00 | Aug 15, 2023 |
| BTIG | Maintained | Buy | $20.00 from $4.00 | Jun 16, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $25.00 | Jun 16, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | May 15, 2023 |
Frequently asked questions
Is MBIO a buy, sell, or hold?
Analysts covering Mustang Bio currently average a Buy rating: 1 buy, 0 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on MBIO?
On May 16, 2024, HC Wainwright & Co. maintained Mustang Bio at Buy with a price target of $2.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.